409 A phase i trial of talimogene laherparepvec for the treatment of peritoneal surface malignancies (TEMPO)

• John Stewart,
• Donna Niedzwiecki,
• John Strickler,
• Niharika Mettu,
• Shannon MacLaughlan,
• Edward Levine,
• Daniel Blazer

Affiliations

John Stewart

1University of Illinois, Chicago, IL, USA

Donna Niedzwiecki

2Duke University School of Medicine, Durham, NC, USA

John Strickler

2Duke University School of Medicine, Durham, NC, USA

Niharika Mettu

2Duke University School of Medicine, Durham, NC, USA

Shannon MacLaughlan

3The University of Illinois, Chicago, IL, USA

Edward Levine

4Wake Forest School of Medicine, Winston-Salem, NC, USA

Daniel Blazer

2Duke University School of Medicine, Durham, NC, USA